[1] Heidelberg Univ Hosp, Dept Dermatol, Neuenheimer Feld 440, D-69120 Heidelberg, Germany
[2] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Mol Med, Paul Klein Ctr Immune Intervent, Mainz, Germany
[3] Roche Innovat Ctr, Neurosci & Rare Dis NRD, Discovery & Translat Area, Roche Pharm Res & Early Dev pRED, Basel, Switzerland
[4] Eberhard Karls Univ Tubingen, Interfak Inst Microbiol, Infect Dis, Tubingen, Germany
[5] Eberhard Karls Univ Tubingen, Cluster Excellence EXC Controlling Microbes Fight, Tubingen, Germany
[6] Eberhard Karls Univ Tubingen, Dept Dermatol, Div Dermatooncol, Tubingen, Germany
[7] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Pediat & Adolescent Med, Dept Pediat Hematol Oncol, Mainz, Germany
[8] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Thrombosis & Hemostasis, Mainz, Germany
[9] German Ctr Cardiovasc Res DZHK, Partner Site RhineMain, D-55131 Mainz, Germany
[10] Hannover Med Sch, Inst Immunol, Hannover, Germany
[11] Univ Med Ctr Hamburg Eppendorf, Inst Syst Immunol, Hamburg, Germany
[12] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Med Microbiol & Hyg, Mainz, Germany
[13] Charite Univ Med Ctr Berlin, Inst Microbiol Infect Dis & Immunol, Berlin, Germany
[14] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Focus Program Translat Neurosci, Mainz, Germany
[15] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Res Ctr Immunotherapy, Mainz, Germany